Literature DB >> 26548824

Bony Regeneration of the Sella after Transsphenoidal Pituitary Surgery.

Mehdi Yahia-Cherif1, Isabelle Delpierre2, Sergio Hassid3, Olivier De Witte4.   

Abstract

OBJECTIVE: The purpose of this study is to demonstrate the possible bony regrowth of the sella after transsphenoidal surgery without any intraoperative sellar reconstruction.
METHODS: Radiologic findings of the sella were reviewed in patients with pituitary tumors treated by transsphenoidal surgery. In 17 patients who had postoperative cranial computed tomography scans, bony regeneration of the sellar floor was evaluated by comparing immediate and late postoperative scans. The bony opening reduction was measured in transverse and sagittal planes.
RESULTS: The median bony opening diameter in the transverse plane was 8.8 mm (interquartile range [IQR] 5.7-11.4) on the first scan and 4.2 mm (IQR 0.8-6.8) on the second scan. In the sagittal plane, it was 4.8 mm (IQR 1.8-6.8) on the first scan and 2.9 mm (IQR 1.6-3.9) on the second scan. These changes occurred in a median time of 36 months (IQR 22-42). There was a statistically significant decrease of the bony opening diameters in both the transverse and sagittal planes (P < 0.0001 and P = 0.0004, respectively). Bone regeneration was observed in 16 of the 17 patients (approximately 94%).
CONCLUSION: There is a natural bony regeneration of the sella after transsphenoidal pituitary surgery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone regeneration; Reoperation; Sella turcica; Transsphenoidal surgery

Mesh:

Year:  2015        PMID: 26548824     DOI: 10.1016/j.wneu.2015.10.073

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

1.  Spontaneous reossification of the sella in transsphenoidal reoperation associated with strontium ranelate.

Authors:  Maria Mercedes Pineyro; Daiana Arrestia; Mariana Elhordoy; Ramiro Lima; Saul Wajskopf; Raul Pisabarro; Maria Pilar Serra
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.